MK-8719, a Novel and Selective O-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy.
J Pharmacol Exp Ther
; 374(2): 252-263, 2020 08.
Article
in En
| MEDLINE
| ID: mdl-32493725
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Beta-N-Acetylhexosaminidases
/
Tau Proteins
/
Tauopathies
/
Enzyme Inhibitors
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
J Pharmacol Exp Ther
Year:
2020
Type:
Article